AbC-19 rapid antibody test
 | This article needs more medical references for verification or relies too heavily on primary sources. (June 2021) |  |
The AbC-19 rapid antibody test is an immunological test for COVID-19 exposure developed by the UK Rapid Test Consortium and manufactured by Abingdon Health. It uses a lateral flow test to determine whether a person has IgG antibodies to the SARS-CoV-2 virus that causes COVID-19. The test uses a single drop of blood obtained from a finger prick and yields results in 20 minutes. The sensitivity of this test is 98.03% while the specificity is 99.56%.[1] This test is paired with an easy-to-use mobile app which allows a trained professional to generate an antibody test certificate for storing on a person's smartphone.[1]
See also[edit]
References[edit]
- ^ a b "AbC-19™ | COVID-19 Rapid Antibody Test and Certificate Solution | IgG". Abingdon Health plc. Retrieved 2021-08-02.
External links[edit]
.svg){kind=small}
 | This immunology article is a stub. You can help Wikipedia by expanding it. |
 | This United Kingdom-related article is a stub. You can help Wikipedia by expanding it. |
 | This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |